Position in MRK
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$73,403,697
+$10,542,670 QoQ
Shares Held
571,235
+9.3% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.50%
of 13F equity value
Holder Rank
#244
of 3,768 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026IFM Investors Pty Ltd holds $685,728,678 across 9 Drug Manufacturers - General names. MRK ranks #4 (10.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
183,394 | $219,968,283 | |
| 2 | JNJ |
Johnson & Johnson
|
559,954 | $142,211,517 | |
| 3 | ABBV |
AbbVie Inc.
|
405,580 | $102,060,151 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
571,235 | $73,403,697 | |
| 5 | AMGN |
Amgen Inc
|
122,804 | $44,469,784 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
287,894 | $36,372,527 | |
| 7 | PFE |
Pfizer Inc
|
1,334,837 | $32,142,874 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
473,184 | $27,264,862 |
All Filings in MRK
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $73,403,697 | 571,235 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $62,861,027 | 522,579 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $53,664,600 | 509,829 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $42,751,759 | 509,374 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $39,933,449 | 504,465 | Shares | Sole | 2025-07-11 | |
| 2024-12-31 | $48,630,698 | 488,849 | Shares | Sole | 2025-04-29 | |
| 2024-09-30 | $60,386,438 | 531,758 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $65,387,693 | 528,172 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $68,850,586 | 521,793 | Shares | Sole | 2024-04-22 | |
| 2023-12-31 | $57,112,198 | 523,869 | Shares | Sole | 2024-01-12 | |
| 2023-09-30 | $53,400,165 | 518,700 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $58,293,758 | 505,189 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $51,126,884 | 480,561 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $51,732,323 | 466,267 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $37,683,183 | 437,566 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $39,287,614 | 430,927 | Shares | Sole | 2022-07-15 | |
| 2021-12-31 | $25,639,298 | 334,542 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $25,440,583 | 338,711 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $26,313,635 | 338,352 | Shares | Sole | 2021-07-16 | |
| 2021-03-31 | $21,464,103 | 278,429 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $19,967,534 | 244,102 | Shares | Sole | 2021-01-13 | |
| 2020-09-30 | $17,348,917 | 209,149 | Shares | Sole | 2020-10-16 | |
| 2020-06-30 | $14,468,681 | 187,103 | Shares | Sole | 2020-07-13 | |
| 2020-03-31 | $20,115,954 | 261,450 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||